GE HealthCare Acquires AI Imaging Analysis Company MIM Software

GE HealthCare aims to leverage MIM Software’s imaging analytics and digital workflow capabilities across various care areas to speed up innovation and differentiate its solutions for benefitting patients and healthcare systems across the world.

MIM Software has a portfolio of innovative imaging solutions that provide various beneficial features, such as the integration of diagnostic images from multiple modalities into treatment plans, automation to reduce repetitive tasks and manual interventions, quantitation and advanced processing in diagnostic imaging and nuclear medicine to determine therapy response and a platform to assist with Theranostics imaging and dosimetry. GE HealthCare plans to integrate MIM Software solutions into its advanced visualization offerings to aid AI-based segmentation and contouring as well as dosimetry analysis for patients during their treatment journeys and in the expanding areas of radiology, molecular imaging, and radiation oncology.

With novel therapies becoming more widely available, providers are depending on advanced imaging, workflow, and digital solutions to gain critical information and help develop faster, more effective treatment plans. With the acquisition of MIM Software, GE HealthCare aims to strengthen its focus and offerings to support the broad practice of precision care across various disease states and imaging practices, including Theranostics in oncology for the treatment of advanced prostate cancer, streamlined workflow solutions in radiation oncology to simplify complex cancer treatment plans, beta-amyloid imaging in neurology for the diagnosis and monitoring of Alzheimer’s patients, and myocardial perfusion to diagnose coronary artery disease (CAD).

“We are committed to providing comprehensive, connected devices and digital solutions that enable providers to improve patient care across multiple specialties,” said Peter Arduini, President & CEO of GE HealthCare. “We expect our efforts to bring these two complementary organizations and innovative product portfolios together to strengthen our capabilities as a leading provider of integrated imaging systems, analytics, and advanced digital workflows across several care areas and pathways – including Theranostics, radiation oncology, urology, neurology and cardiology. Now and in the future, we are working to transform patient care.”

“Our anticipated acquisition of MIM Software will mark a key moment in the evolution of our technology. By integrating MIM Software’s cutting-edge imaging analytics and AI-driven solutions with GE HealthCare’s advanced medical technology, we are not just expanding our capabilities, but joining together to embrace the possibilities of precision care. This intended merger is a fusion of innovative visions, aimed at evolving the way we detect, treat, and manage disease,” added Taha Kass-Hout, MD, MS, Chief Technology Officer of GE HealthCare. "GE HealthCare is committed to developing smart, AI-powered devices that cater to specific disease states, thereby enabling clinicians to deliver more personalized care. We expect the integration of MIM Software will also advance our efforts in connecting data across care pathways. It is a leap towards a future where healthcare is more precise, connected, and efficient, with the goal of benefitting providers and patients worldwide.”

“We are excited by the prospect of joining GE HealthCare and thrilled to share this exciting news,” said Andrew Nelson, CEO of MIM Software. “Over the past two decades, we have worked to develop innovative vendor agnostic products and deliver quality services to earn the trust of our customers – this will not change. As a part of GE HealthCare, we anticipate developing new and increasingly integrated digital solutions to meet our customers’ most complex and pressing needs, today and into the future. Together, we will build upon our shared legacies of enhancing patient care.”